Αρχική World News EMA Recommends Granting a Marketing Authorisation for Lurbinectedin World News EMA Recommends Granting a Marketing Authorisation for Lurbinectedin Από Ogkologos - 30 Απριλίου, 2026 331 0 Facebook Twitter Google+ Pinterest WhatsApp It is indicated for the maintenance treatment of adult patients with extensive-stage small cell lung cancer Source ΠΑΡΟΜΟΙΑ ΑΡΘΡΑΠΕΡΙΣΣΟΤΕΡΑ ΑΠΟ ΤΟΝ ΔΗΜΙΟΥΡΓΟ Ahead of the Special European Council Meeting on 26-27 November, ESMO Calls on EU Governments to Continue Support for the Cancer Mission European Parliament backs key priorities advocated by ESMO for cancer research and innovation FDA approves giredestrant in combination with everolimus for ER-positive, HER2-negative, ESR1-mutated locally advanced or metastatic breast cancer MOST POPULAR How will new cancer medicines be approved in the future? 2 Δεκεμβρίου, 2021 FDA Approves Acalabrutinib with Bendamustine and Rituximab for Previously Untreated Mantle... 21 Φεβρουαρίου, 2025 FDA Approves Dostarlimab-gxly with Chemotherapy for Endometrial Cancer 11 Αυγούστου, 2023 What Cancer Caregivers Should Know About Hospice Care at Home: A... 31 Αυγούστου, 2021 Φόρτωση περισσοτέρων HOT NEWS How keeping active during cancer treatment has helped Mary and Keith Cancer Survivor with Strong Family History Was Denied Regular Screening Because... Marginal Benefit in Overall and Progression-Free Survival from New Anticancer Drugs 9 Ways to Use Social Media for Support Throughout Your Cancer...